Art. 53 Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 20…

Other reporting obligations relevant for subject safety

In forcesince 16 Apr 2014cited 1×
1.

The sponsor shall notify the Member States concerned through the EU portal of all unexpected events which affect the benefit-risk balance of the clinical trial, but are not suspected unexpected serious adverse reactions as referred to in Article 42. That notification shall be made without undue delay but no later than 15 days from the date the sponsor became aware of this event.

2.

The sponsor shall submit to the Member States concerned, through the EU portal, all inspection reports of third country authorities concerning the clinical trial. When requested by a Member State concerned, the sponsor shall submit a translation of the report or of its summary in an official language of the Union indicated in the request.

  • Gesetz über den Verkehr mit Arzneimitteln40b42aLaw

    … 536/2014 weitergegeben werden, f) im Fall unerwarteter Ereignisse nach Artikel 53 Absatz 1 der Verordnung (EU) Nr. 536/2014 pseudonymisiert vom Sponsor an das EU-Portal weitergegeben werden, 2. im Fall eines Widerrufs der nach Satz 1 und …